Some Indian companies that had put off production of HIV/AIDS meds while they waited for the government to sign contracts are now having to seriously ramp up because of shortages of some meds, Reuters reports. Aurobindo Pharma is among those and expects to supply 2.4 million tablets by the end of October, a senior executive told the news service. The National AIDS Control Organization website says that India needs 7.2 million tablets a month to meet demand, and Reuters says that as many as 150,000 patients risk going without meds this month because bureaucratic delays mired the process. Story